Taxol^®, which is also known as paclitaxel, is a chemotherapeutic agent widely used to treat different cancers. Since the discovery of its antitumoral activity, Taxol^® has been used to treat over one million patients, making it one of the most widely employed antitumoral drugs. Taxol^® was the first microtubule targeting agent described in the literature, with its main mechanism of action consisting of the disruption of microtubule dynamics, thus inducing mitotic arrest and cell death. However, secondary mechanisms for achieving apoptosis have also been demonstrated. Despite its wide use, Taxol^® has certain disadvantages. The main challenges facing Taxol^® are the need to find an environmentally sustainable production method based on the use of microorganisms, increase its bioavailability without exerting adverse effects on the health of patients and minimize the resistance presented by a high percentage of cells treated with paclitaxel. This review details, in a succinct manner, the main aspects of this important drug, from its discovery to the present day. We highlight the main challenges that must be faced in the coming years, in order to increase the effectiveness of Taxol^® as an anticancer agent.

Currently, the effect of exposure to indoor air contaminants and the presence of dampness at home on respiratory/atopic health is of particular concern to physicians. The measurement of volatile organic compounds (VOCs) in exhaled breath is a useful approach for monitoring environmental exposures. A great advantage of this strategy is that it allows the study of the impact of pollutants on the metabolism through a non-invasive method. In this paper, the levels of nine VOCs (acetone, isoprene, toluene, p/m-xylene, o-xylene, styrene, benzaldehyde, naphthalene, and 2-ethyl-1-hexanol) in the exhaled breath of subjects exposed and not exposed to home dampness were assessed. Exhaled breath samples were collected from 337 mother–child pairs of a birth cohort and analysed by gas-chromatography–mass-spectrometry. It was observed that the levels of 2-ethyl-1-hexanol in the exhaled breath of the mothers were significantly influenced by exposure to household humidity. In the case of the infants, differences in some of the VOC levels related to home dampness exposure; however, they did not reach statistical significance. In addition, it was also found that the eosinophil counts of the mothers exposed to home dampness were significantly elevated compared to those of the non-exposed mothers. To our knowledge, these findings show, for the first time, that exposure to home dampness may influence VOC patterns in exhaled breath.

Environmental exposures throughout the life of the subjects (exposome) could have a negative effect on their health outcomes. From this perspective, analysis of volatile organic compounds (VOCs) in human exhaled breath is emerging as a non-invasive tool to identify and check exposure to harmful agents. Breath analysis is also a helpful technique for human metabolism assessment, which allows for examining the impact of environmental exposures on organisms (biomonitoring). In this paper, a comprehensive review has been carried out to assess the use of breath analysis by mass spectrometry-based technologies for monitoring environmental exposures. Records of the last 20 years from three databases (PubMed/Medline, Scopus, and Web of Science) have been evaluated independently by two reviewers. A total of 38 studies fulfilled the criteria for eligibility. It has been compiled information about environmental exposures that have been monitored by breath analysis using mass spectrometry-based analytical platforms, as well as the most commonly used protocols of breath sampling, analytical techniques, and statistical methods. In addition, special emphasis has been placed on the huge range of VOCs selected as potential markers of environmental exposures. Despite the potential of breath analysis for monitoring human exposure, further research is needed to identify useful markers to establish it as a routine tool.